Margarethe Wacker

1.1k total citations
37 papers, 749 citations indexed

About

Margarethe Wacker is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Margarethe Wacker has authored 37 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 11 papers in Epidemiology and 8 papers in Physiology. Recurrent topics in Margarethe Wacker's work include Chronic Obstructive Pulmonary Disease (COPD) Research (25 papers), Chronic Disease Management Strategies (11 papers) and Asthma and respiratory diseases (7 papers). Margarethe Wacker is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (25 papers), Chronic Disease Management Strategies (11 papers) and Asthma and respiratory diseases (7 papers). Margarethe Wacker collaborates with scholars based in Germany, Netherlands and United States. Margarethe Wacker's co-authors include Reiner Leidl, Rolf Holle, Claus Vogelmeier, Rudolf A. Jörres, Stefan Karrasch, Joachim Heinrich, Manuel Huber, Annette Peters, Annika Karch and Armin Koch and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and European Respiratory Journal.

In The Last Decade

Margarethe Wacker

35 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Margarethe Wacker Germany	18	504	212	153	126	86	37	749
Jenő P. Marton United States	17	481 1.0×	221 1.0×	152 1.0×	105 0.8×	101 1.2×	20	766
Sixten Borg Sweden	18	609 1.2×	300 1.4×	389 2.5×	144 1.1×	164 1.9×	43	1.3k
Julia F. Slejko United States	15	268 0.5×	313 1.5×	101 0.7×	163 1.3×	269 3.1×	68	1.0k
Willem M. van der Wal Netherlands	12	158 0.3×	161 0.8×	134 0.9×	44 0.3×	64 0.7×	15	751
Kieran Rothnie United Kingdom	16	732 1.5×	306 1.4×	190 1.2×	69 0.5×	30 0.3×	66	998
Yevgeniy Samyshkin United Kingdom	17	176 0.3×	71 0.3×	167 1.1×	117 0.9×	137 1.6×	40	717
Britt B. Newsome United States	17	152 0.3×	82 0.4×	148 1.0×	74 0.6×	87 1.0×	29	1.2k
Jacek Polański Poland	16	191 0.4×	170 0.8×	77 0.5×	142 1.1×	52 0.6×	47	906
S Hummel United Kingdom	11	191 0.4×	514 2.4×	91 0.6×	183 1.5×	467 5.4×	14	1.4k
Marie-France Beauchesne Canada	22	501 1.0×	532 2.5×	169 1.1×	125 1.0×	37 0.4×	85	1.3k

Countries citing papers authored by Margarethe Wacker

Since Specialization

Citations

This map shows the geographic impact of Margarethe Wacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margarethe Wacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margarethe Wacker more than expected).

Fields of papers citing papers by Margarethe Wacker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margarethe Wacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margarethe Wacker. The network helps show where Margarethe Wacker may publish in the future.

Co-authorship network of co-authors of Margarethe Wacker

This figure shows the co-authorship network connecting the top 25 collaborators of Margarethe Wacker. A scholar is included among the top collaborators of Margarethe Wacker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margarethe Wacker. Margarethe Wacker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lutter, Johanna I., Margarethe Wacker, Rudolf A. Jörres, et al.. (2019). <p>Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET</p>. International Journal of COPD. Volume 14. 1423–1439. 24 indexed citations

Lutter, Johanna I., Margarethe Wacker, Joachim Winter, et al.. (2019). Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study. Health Economics Review. 9(1). 26–26. 13 indexed citations

Luzak, Agnes, Stefan Karrasch, Margarethe Wacker, et al.. (2018). Association of generic health-related quality of life (EQ-5D dimensions) and inactivity with lung function in lung-healthy German adults: results from the KORA studies F4L and Age. Quality of Life Research. 27(3). 735–745. 3 indexed citations

Wacker, Margarethe, Rudolf A. Jörres, Reiner Leidl, et al.. (2017). The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort. International Journal of COPD. Volume 12. 3437–3448. 21 indexed citations

Kahnert, Kathrin, Peter Alter, David Young, et al.. (2017). The revised GOLD 2017 COPD categorization in relation to comorbidities. Respiratory Medicine. 134. 79–85. 35 indexed citations

Holle, Rolf, Robert Bals, Timm Greulich, et al.. (2017). Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients. Respiratory Research. 18(1). 60–60. 17 indexed citations

Kahnert, Kathrin, Frank Biertz, Andreas Lechner, et al.. (2017). Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort. Respiratory Research. 18(1). 14–14. 14 indexed citations

Houben‐Wilke, Sarah, Rudolf A. Jörres, Robert Bals, et al.. (2016). Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences–Comorbidities Network Study. American Journal of Respiratory and Critical Care Medicine. 195(2). 189–197. 69 indexed citations

Schwarzkopf, Larissa, et al.. (2016). Impact of chronic ischemic heart disease on the health care costs of COPD patients – An analysis of German claims data. Respiratory Medicine. 118. 112–118. 10 indexed citations

10.

Wacker, Margarethe, Rudolf A. Jörres, Annika Karch, et al.. (2016). Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies. Respiratory Research. 17(1). 81–81. 27 indexed citations

11.

Wacker, Margarethe, Rolf Holle, Frank Biertz, et al.. (2016). Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication. PLoS ONE. 11(10). e0163408–e0163408. 33 indexed citations

12.

Hoogendoorn, Martine, Talitha Feenstra, Yumi Asukai, et al.. (2016). Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?. Value in Health. 19(6). 800–810. 10 indexed citations

13.

Wacker, Margarethe, Rudolf A. Jörres, Annika Karch, et al.. (2016). Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulmonary Medicine. 16(1). 70–70. 79 indexed citations

14.

Leidl, Reiner, Margarethe Wacker, & Larissa Schwarzkopf. (2016). Better understanding of the health care costs of lung cancer and the implications. Expert Review of Respiratory Medicine. 10(4). 373–375. 8 indexed citations

15.

Hoogendoorn, Martine, Talitha Feenstra, Yumi Asukai, et al.. (2015). Patient Heterogeneity In Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (Copd): are Current Models Suitable to Evaluate Personalized Medicine. Value in Health. 18(7). A694–A694. 2 indexed citations

16.

Schwarzkopf, Larissa, Margarethe Wacker, Rolf Holle, et al.. (2015). Cost-components of lung cancer care within the first three years after initial diagnosis in context of different treatment regimens. Lung Cancer. 90(2). 274–280. 29 indexed citations

17.

Huber, Manuel, Margarethe Wacker, Claus Vogelmeier, & Reiner Leidl. (2015). Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review. PLoS ONE. 10(4). e0123292–e0123292. 36 indexed citations

18.

Wacker, Margarethe, Matthias Hünger, Holger Schulz, et al.. (2014). Health economics of COPD: First results of the new German COSYCONET cohort compared to population-based controls from KORA. European Respiratory Journal. 44(Suppl 58). 4440–4440.

19.

Wacker, Margarethe, Matthias Hünger, Stefan Karrasch, et al.. (2014). Health-related quality of life and chronic obstructive pulmonary disease in early stages – longitudinal results from the population-based KORA cohort in a working age population. BMC Pulmonary Medicine. 14(1). 134–134. 19 indexed citations

20.

Wacker, Margarethe, Rolf Holle, Joachim Heinrich, et al.. (2013). The association of smoking status with healthcare utilisation, productivity loss and resulting costs: results from the population-based KORA F4 study. BMC Health Services Research. 13(1). 278–278. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact